The Medical Affairs Portal is an online medical resource for scientific and clinical information for healthcare professionals active in Belgium or Grand Duchy of Luxemburg. I accept that this portal may contain scientific, non-public information on the use of GSK products outside the terms of marketing authorisation within Belgium and/or the Grand Duchy of Luxembourg (off-label use).

For Healthcare professionals

The Medical Affairs Portal is an online medical resource for scientific and clinical information for healthcare professionals active in Belgium or Grand Duchy of Luxemburg. I accept that this portal may contain scientific, non-public information on the use of GSK products outside the terms of marketing authorisation within Belgium and/or the Grand Duchy of Luxembourg (off-label use).

Vaccine Thermostability Tool

Communication preferences

Reporting a possible side effect

For Healthcare professionals

Momelotinib mechanism of action

2:50 min Published on 01-01-2024

Momelotinib inhibits key drivers of myelofibrosis: dysregulated signalling in the JAK-STAT pathway and hyperactivation of the ACVR1 pathway.

NX-BE-MML-VID-240003

Get in touch

Our team of medical experts provide the latest and most relevant medical information through our content and events.
With just a click of the button, you can access a wealth of knowledge about the latest medical topics.

Contact us

This website is intended for health care professionals (HCPs) active in Belgium or Grand Duchy of Luxemburg only.
It includes learning and medical information for multiple therapeutic areas, and may include presentations, publications or other multimedia materials generated by third parties. HCPs may navigate to content if it is relevant to their practice and area of interest. Multimedia content is made available for HCPs specializing in a respective therapeutic area for learning and information purposes only to address the need of the medical community to better understand investigational interventions and the physiology of disease. Links to third party websites and resources are made available for your convenience only. HCPs are responsible for any reliance on the information available on linked sites and must use their professional judgment and discretion when choosing to use any such information provided.
GSK does not support or endorse any use of its products that is not consistent with the approved prescribing information in the official Summary of product characteristics.
For more information, please click on the links presented for Summary of product characteristics, the delivery status and the Belgian price of the product.:
Summary of product characteristics (nl)
Summary of product characteristics (fr)